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Abstract
During human pregnancy, the production of 17-beta-estradiol (E2) rises steadily to eighty fold at
term, and placenta has been found to specifically bind estrogens. We have recently demonstrated
the expression of estrogen receptor alpha (ER-alpha) protein in human placenta and its localization
in villous cytotrophoblast (CT), vascular pericytes, and amniotic fibroblasts. In vitro, E2 stimulated
development of large syncytiotrophoblast (ST) aggregates. In the present study we utilized ER-beta
affinity purified polyclonal (N19:sc6820) and ER-alpha monoclonal (clone h-151) antibodies.
Western blot analysis revealed a single ~52 kDa ER-beta band in chorionic villi (CV) protein
extracts. In CV, strong cytoplasmic ER-beta immunoreactivity was confined to ST. Dual color
immunohistochemistry revealed asymmetric segregation of ER-alpha in dividing villous CT cells.
Prior to separation, the cell nuclei more distant from ST exhibited high ER-alpha, while cell nuclei
associated with ST showed diminution of ER-alpha and appearance of ER-beta. In trophoblast
cultures, development of ST aggregates was associated with diminution of ER-alpha and appearance
of ER-beta immunoreactivity. ER-beta was also detected in endothelial cells, amniotic epithelial cells
and fibroblasts, extravillous trophoblast (nuclear and cytoplasmic) and decidual cells (cytoplasmic
only). In addition, CFK-E12 (E12) and CWK-F12 (F12) monoclonal antibodies, which recognize ~64
kDa ER-beta with hormone binding domain, showed nuclear-specific reactivity with villous ST,
extravillous trophoblast, and amniotic epithelium and fibroblasts. Western blot analysis indicated
abundant expression of a ~64 kDa ER-beta variant in trophoblast cultures, significantly higher when
compared to the chorionic villi and freshly isolated trophoblast cell protein extracts. This is the
first report on ER-beta expression in human placenta and cultured trophoblast. Our data indicate
that during trophoblast differentiation, the ER-alpha is associated with a less, and ER-beta with the
more differentiated state. Enhanced expression of ~64 kDa ER-beta variant in trophoblast cultures
suggests a unique role of ER-beta hormone binding domain in the regulation of trophoblast
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differentiation. Our data also indicate that asymmetric segregation of ER-alpha may play a role in
asymmetric division of estrogen-dependent cells.
Background
Estrogens affect a variety of tissues, including reproductive
tissues, bone, liver, cardiovascular system and brain. Table
1 lists the classical and non-classical estrogen sensitive tis-
sues and cells [1]. Although several previous studies have
shown that human placenta binds estradiol (E2) [2–4],
and estrogens influence various aspects of placental func-
tion and fetal development in humans and primates [5–
11], the placenta as a target for estrogens is missing. The
reason might be an inability of former studies to detect ex-
pression of estrogen receptor alpha (ERα) and its immu-
noreactivity in placental components [12,13]. Yet, forms
of the estradiol receptor of differing stability have been de-
tected in human placental tissue [14]. This indicates that
some determinants of placental ERα may possibly under-
go denaturation during tissue processing and become un-
detectable, e.g. in paraffin sections.
On the other hand, we have recently shown ERα expres-
sion in human term placenta by western blot analysis.
ERα immunoreactivity was confined to villous and cul-
tured cytotrophoblast (CT) cells but not syncytiotrophob-
last (ST). We also localized ERα immunoreactivity in
villous vascular pericytes and extravillous (amniotic) fi-
broblasts but not in villous endothelial cells, amniotic ep-
ithelium, extravillous trophoblast (EVT) or decidual cells.
In tissue culture, E2 stimulated trophoblast differentia-
tion into syncytial aggregates [15]. To our knowledge, no
attempt has been so far made to study placental expres-
sion of ER beta (ERβ).
Although it was first believed that estrogen receptors were
predominantly cytoplasmic, it was later proposed that
they are located exclusively within the nucleus. It is now
clear that these receptors can be found in both the cyto-
plasm and nucleus, with the ratio dependent upon the cell
type and physiological conditions. Some studies also indi-
cate that estrogen receptors reside on the plasma mem-
brane and modulate cellular activity without directly
associating with DNA [16]. Human ERβ is encoded by
477 amino acids (~52 kDa) and has substantial hom-
ology to ERα (66 kDa) [17,18]. Although both estrogen
receptors (ERs) can be expressed in various estrogen-sen-
sitive tissues and cells, evidence is accumulating that their
expression varies during cellular proliferation and differ-
entiation [19]. It appears quite clear today that ERβ has bi-
ological roles that are distinct from those of ERα, and
certain results indicate that ERβ can have effects opposite
to those of the ERα [20,21].
Although some in vitro studies suggest both ERs may play
redundant roles, a dissimilar tissue distribution indicates
otherwise. ERα (αERKO) and ERβ knockout (βERKO) fe-
male mice possess a normally developed reproductive
tract and maintain expression of the opposite ER [22]. The
αERKO female is infertile and exhibits a hypoplastic uter-
us that is refractory to estrogens. The ovaries of the αERKO
female are consistently polycystic and lack evidence of
spontaneous ovulation. In contrast, the βERKO female ex-
hibits a hormonally responsive uterus and grossly normal
ovaries, but is subfertile in terms of the frequency and size
of litters. Double ER knockout (DERKO) mice are infer-
tile, possess the expected reproductive tract structures, but
exhibit a remarkably distinct ovarian phenotype charac-
terized by postnatal loss of oocytes and redifferentiation
of the remaining somatic cells to Sertolilike cells. This
"sexreversal" in the DERKO ovary is accompanied by the
ectopic expression of testisspecific genes (reviewed in ref-
erence [22]).
A recent study of βERKO mice has shown that ERβ is not
required for the normal prepubertal development of the
mammary gland but for organization and adhesion of ep-
ithelial cells during pregnancy and hence for differentiat-
ed tissue morphology [23]. These observations indicate a
possibility of complementary (sequential) roles of ERα
and ERβ, since ERα appears to be required for the basic de-
velopment of estrogen sensitive tissues and ERβ seems to
be required for their functional maturation.
Besides the ~52 kDa ERβ, additional related forms have
been identified at the RNA level, often denoted as "ERβ
B". They would generate ~56, 61 and 63 kDa ERβ proteins
[24]. Recently developed monoclonal antibodies made to
the human ERβ hormone binding domain have been
shown to identify ~52 kDa and an additional ~62–64 kDa
band in protein extracts from granulosa cells of several
mammalian species. Immunohistochemical studies with
these antibodies revealed nuclear-specific localization of
the ERβ protein in granulosa cells of the rat ovary and in
epithelial and some stromal cells of mouse and rat epidi-
dymis. Epitope mapping studies indicated that the E12
and F12 antibodies recognize overlapping peptide se-
quences in the C-terminal region of the hormone-binding
domain, a region that is highly conserved among species
[18].
Villous CT cells are a type of stem cell which divides dur-
ing pregnancy including the term placenta [25–27]. How-
ever, if the division is symmetric, i.e., resulting in twoReproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/36
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identical cells, both cells should either proliferate or dif-
ferentiate. The former situation might result in placental
site trophoblastic tumor or choriocarcinoma [28], the lat-
ter in the loss of the ability of the villous trophoblast to
proliferate. However, ten years ago, biologists began to
gain insight into the cellular mechanisms by which a cell
divides into two cells of different developmental poten-
tials, a process known as asymmetric division. Asymmet-
ric division is a fundamental means of generating cell
diversity and may involve extrinsic or intrinsic factors.
With extrinsic factors, daughter cells are equivalent after
separation but adopt different fates due to their interac-
tions with the environment. With intrinsic factors, une-
qual amounts of cell-fate determinants are distributed
into the two cells prior to their separation [29]. Among
the intrinsic factors underlying asymmetric division, the
interactions of the Numb differentiation-associated pro-
tein with Notch proliferation-associated signaling is the
model most widely studied, ranging from bacteria, yeast,
and Drosophila to mammals [30]. Mammalian cells
known to exhibit asymmetric division include diverse cell
types such as neuronal cells, thymocytes, and satellite cells
involved in myogenesis, and the list is growing [29–32].
The aim of present study was to investigate expression and
localization of ERβ in normal term placentae as compared
to that of ERα. Our data indicate that virtually all cellular
compartments of the human placenta express either ERα,
ERβ, or both. In addition, we identified asymmetric ERα
segregation in dividing villous CT cells.
Materials and Methods
Tissues
Seven normal placentae from deliveries between 36 and
38 weeks of pregnancy were investigated. The source of
placental tissue was women with normal pregnancies ad-
mitted to the University of Tennessee Medical Center. Ex-
cluded were patients with blood transferable infections,
e.g., hepatitis and HIV, and apparent ascendent placental
infections. The study was approved by the Institutional
Review Board.
Tissue processing
The processing started within 30–60 minutes after deliv-
ery. Tissue blocks of placental samples were frozen in op-
timum cutting temperature (O.C.T.) compound (Miles
Inc., Elkhart, IN) and stored at -80°C. Frozen sections (7
µm thickness) were fixed in acetone and processed as de-
scribed previously [15]http://www.RBEj.com/content/1/
1/36 and indicated below. All chemicals, except where
specified otherwise, were purchased from Sigma Chemi-
cal Co., St. Louis, MO.
Dual color immunohistochemistry for Thy-1 of mesenchy-
mal cells and cytokeratin of epithelial cells
To determine a relationship between placental mesenchy-
mal and epithelial components, the slides were subjected
to dual color immunohistochemistry for Thy-1 and cytok-
eratin (CK) immunoreactivity (Thy-1/CK). The slides
were first immunostained for Thy-1 differentiation pro-
tein of mesenchymal cells (placental fibroblasts, pericytes
and decidual cells) as described previously [15], but with-
out hematoxylin counterstain and dehydratation. Briefly,
specimens were washed with phosphate buffered saline
(PBS) and incubated 20 minutes with mouse-anti human
Thy-1, clone F10-44-1 [33,34] (5 µg/ml in PBS) reacting
with placental villous pericytes, extravillous fibroblasts,
and decidual cells [15]. After extensive washing in PBS,
specimens were incubated 20 minutes with swine anti-
mouse IgG peroxidase conjugate (SwAM; SEVAC, Prague,
Czech Republic) diluted 1:50 and preabsorbed with rat
kidney homogenate [15]. Antigen-antibody complexes
were detected by standard diaminobenzidine technique
(brown color).
Table 1: Estrogen-sensitive tissues and cells (data from reference [1])
Classical targets Non-classical targets
Ovary Kidney
Vagina Islets of Langerhans
Uterus Liver
Mammary gland Bone
Adrenal gland Cardiovascular system
Prostate Macrophages
Pituitary gland Thymocytes
Hypothalamus Lymphoid cells
Leydig cells Endothelial cells
Osteoblastic cells
Glial cells
Schwann cellsReproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/36
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After extensive washes in PBS, the slides were incubated
for 20 minutes with mouse anti-human cytokeratin 18,
clone DC10 (DAKO Corporation, Carpinteria, CA) dilut-
ed 1:50 and peroxidase-coupled secondary antibody as
above. Antigen-antibody complexes were detected by a
DABNi detection kit according to the supplier's manual
(Vector Laboratories, Inc., Burlingame, CA), giving the
substrate dark blue color. This contrasted with the brown
color resulting from the first sequence of immunoreagents
(Thy-1 immunostaining). The slides were dehydrated and
mounted, without hematoxylin counterstain. A control
procedure consisted of dual color immunohistochemistry
as above, but both primary antibodies were replaced with
PBS.
Since the diaminobenzidine reaction product masks the
antigen and catalytic sites of the first sequence of immu-
noreagents and thus prevents interaction with the rea-
gents of the second sequence [35], a possibility of co-
expression in the same cell types has been investigated.
Therefore, another set of slides was similarly processed,
with the opposite order of primary antibodies (CK/Thy-
1). In addition, two sets of slides were immunostained for
Thy-1 or CK expression alone, followed by hematoxylin
counterstain (not shown).
Differential interference contrast images were captured
with a DEI-470 CCD Video Camera System (Optronics
Engineering, Goleta, CA) with detail enhancement and
CG-7 color frame grabber (Scion Corporation, Frederick,
MD) supported by Scion Image public software developed
at the National Institutes of Health (Wayne Rasband,
NIH, Bethesda, MD). Captured images were compiled us-
ing Microsoft® Power-Point® 97 SR-2 (Microsoft Corpora-
tion, Redmont, WA) and Microsoft Photo Editor 3.0
(Microsoft Corporation).
Peroxidase immunohistochemistry for ERα and ERβ
Tissue sections were processed for ERα and ERβ immu-
noexpression using indirect single color immunoperoxi-
dase immunohistochemistry [15]. For ERβ, the slides were
incubated at 4°C overnight with affinity purified goat-anti
human ERβ polyclonal antibody – ERβ (N-19): sc6820
raised against a peptide mapping at the amino terminus of
ERβ of human origin (Santa Cruz Biotechnology, Santa
Cruz, CA) diluted 1:20 in PBS. After extensive washing,
the slides were incubated with biotinated donkey anti-
goat polyclonal antibody (DAKO) pre-absorbed with rat
kidney homogenate [15], followed by peroxidase-coupled
streptavidin, and the peroxidase visualized by diami-
nobenzidine as recommended by the kit (LSAB) vendor
(DAKO). The slides were dehydrated and mounted, with-
out hematoxylin counterstain. Sections incubated with-
out the primary antibody but with PBS were used as
negative controls. Images were captured and processed as
indicated above. We used ERα/ERβ dual color immuno-
histochemistry for co-localization of both ERs.
Specificity of ERβ polyclonal antibody was confirmed by
absorption with blocking peptide. The blocking peptide
sc-6820 P (Santa Cruz Biotechnology) for N-19 ERβ anti-
body was mixed with the ERβ antibody at a 10:1 weight
ratio, and incubated overnight at 4°C then 2 h at room
temperature before the peptide-absorbed antibody was
utilized for immunohistochemistry (PA/ERβ, Figure 2H)
and western blot controls (PA/ERβ, Figure 6B). As an ad-
ditional negative control, we tested reactivity of ERα and
ERβ antibodies with cdk2 immunoprecipitates (see
below).
Cell separation and culture
Placental tissue was digested and trophoblast cells isolat-
ed and cultured as described previously [15,36]. Briefly,
the cells collected after digestion were pooled, washed
twice in DMEM containing 25 mM HEPES and 4500 mg/
L glucose (DMEM-HG), diluted to 10 ml in DMEM-HG
supplemented with heat inactivated 5% fetal bovine se-
rum (FBS) and antibiotics (50 µg/ml gentamycin, 100 U/
ml penicillin, and 100 µg/ml streptomycin), and viable
large nucleated cells (95% in trypan blue exclusion test)
were counted. Cells were seeded in 60 mm Falcon Prima-
ria petris (Fisher Scientific, Pittsburgh, PA), in the amount
of 7 × 106 per dish cells in 3 ml DMEM-HG with 5% FBS
+ antibiotics as above, and cultured in an humidified at-
mosphere with 5% CO2  at 37°C. The medium was
changed every 24 hours.
Immunohistochemical detection of ERα on trophoblast
cultures (four or eight chamber slides) was performed as
described previously [15], and that of ERβ as above. To
prepare cell lysates, freshly isolated trophoblast cells and
early (16–24 h) and late trophoblast cultures (72–96 h)
were washed twice with ice-cold PBS, lysed by adding ice-
cold lysis buffer (20 mM Tris pH 7.5, 200 mM NaCl) con-
taining 1 mM sodium orthovanadate, 0.25% Nonidet P-
40, 10 mM sodium fluoride, and 1 mM phenylmethylsul-
fonyl fluoride, sonicated, centrifuged, and supernatants
stored at -80°C until use [15].
Western blot analysis
Placental tissue and trophoblast culture protein extracts
were used for the detection of ERβ protein, as previously
described [15]. Protein samples (42 µg) were separated on
10% SDS PAGE and transferred onto nitrocellulose mem-
branes. The membranes were washed in Tris-buffered sa-
line containing 0.05% Tween 20 (TBST), blocked by
immersing the membrane in 0.5% casein in TBST for 1 h
then incubated at 4°C overnight with affinity purified
goat anti-ERβ N-19 antibody (Santa Cruz Biotechnology)
diluted 1:4000 in blocking reagent. After washing in TBST,Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/36
Page 5 of 21
(page number not for citation purposes)
Figure 1
Dual color for Thy-1 differentiation protein and cytokeratin (Thy-1/CK), single color ERβ, and control staining (ctr) in CV and 
placental membranes. [A–C] Corresponding sections through the terminal villi of normal term placenta: s, syncytiotrophob-
last; arrowheads, villous blood sinusoids. [D–F] Placental membranes: e, amniotic epithelium; c, connective tissue; t, extravil-
lous trophoblast; t/d, trophoblast/decidua interface; d, decidual cells; arrowhead, Thy-1+ fibroblasts. [G–I] Placental basal plate 
decidua (d); arrowheads, comparison of ERβ and control staining. [J–L] Placental basal plate extravillous trophoblast (t) and 
decidua compartments (d); arrowhead indicates nuclear staining of decidual cell. No hematoxylin counterstain. Details in text.
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Figure 2
Immunolocalization of ERs in placental membranes and ERβ peptide-absorbed antibody control. [A] Amniotic epithelium with 
ERβ+ (solid arrow) and ERβ- nuclei (white arrow). [B] Basal plate EVT with high (solid arrow) and diminishing ERβ staining 
(white arrow). [C] Immunolocalization of ERβ in vascular endothelial cells (ec) of a stem villus. [D] Cytotrophoblast cell merg-
ing with ST (st) shows nuclear ERβ immunoreactivity (solid arrow) but ST nuclei are unstained (white arrow). [E] Rarely seen 
nuclear ERα immunoreactivity in the basal plate decidual cells. [F] Control. [G] EVT in lower magnification, representing ERβ 
positive control for [H], which is a parallel section incubated with peptide-absorbed ERβ antibody (PA/ERβ). Bar in C = 50 µm 
for [A–C], 20 µm for [D], and 100 µm for [E-H]. No nuclear counterstain except in panel [D]. Details in text.
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the filters were incubated with peroxidaseconjugated don-
key anti-goat IgG secondary antibody (Jackson Immu-
noresearch) for 1 h at a dilution of 1:5000 in blocking
reagent. After washing in TBST, the ERβ protein was visu-
alized with a chemiluminescent detection system (ECL;
Amersham Pharmacia Biotech, Piscataway, NJ) as recom-
mended by the manufacturer, and exposed on Kodak XAR
film (Eastman Kodak, Rochester, NY). Primary antibodies
for actin (clone C4, Boehringer Mannheim Corp., Indian-
apolis, IN) and ERα (clone h-151, StressGen Biotechnol-
ogies Corp, Victoria, BC; 0.1 µg/ml) were also used for
western blot analysis as described [15].
Monoclonal antibodies to ERβ hormone binding domain
We also used recently developed and well defined mouse
monoclonal antibodies CFK-E12 (E12) and CWK-F12
(F12), which were made against human ERβ amino acids
256–505 hormone binding domain lacking the F domain
[18]. The antibodies were kindly donated by Dr. Benita S.
Katzenellenbogen of the Department of Molecular and In-
tegrative Physiology, University of Illinois College of
Medicine, Urbana, Illinois.
We used both antibodies in the form of ascites fluid (1
mg/ml), at 10 µg/ml dilution for immunohistochemistry
and 1 µg/ml for western blot analysis (4°C overnight).
This was followed by peroxidaseconjugated and rat kid-
ney preabsorbed swine anti-mouse IgG (SEVAC, Prague)
or goat anti-mouse IgG and IgM (Jackson Immunore-
search), respectively.
Immunoprecipitation
Cyclin-dependent kinase 2 (cdk2) immunoprecipitates
(IP) were utilized as negative controls for ERα mono-
clonal and ERβ polyclonal antibodies. The cdk2 (M2) af-
finity purified rabbit polyclonal antibody raised against a
peptide mapping at the carboxy terminus of cdk2 of hu-
man origin (Santa Cruz Biotechnology) was utilized.
Equal amounts (200 µg) of protein from each sample
were immunoprecipitated with 0.5 µg cdk2 antibody in
300 µl IP buffer [50 mM Tris (pH 7.5), 5 mM EDTA, 20
mM glycerol, 150 mM NaCl, and 1% NP-40] and 25 µl
protein A/G agarose beads (Santa Cruz Biotechnology) on
an orbital shaker overnight at 4°C. Immunoprecipitates
were collected by centrifugation (11000 × g for 10 min at
4°C), washed five times with 500 µl TG-buffer containing
20 mM Tris, 250 mM NaCl, and 0.5% NP-40. For western
blot analysis, IP were resuspended in 20 µl 2 × SDS/sam-
ple (Laemmli) buffer and the supernatants were resolved
by SDS-PAGE. In parallel, the western blots with original
protein lysates were processed. The ERs were detected by
probing with ERα and ERβ antibodies as indicated above.
The cyclin E antibody served as a positive control for cdk2
IP, as described previously [15].
Quantitative analysis of ERα and ERβ immunoreactivity
Immunohistochemical color images were loaded into Sci-
on Image software, converted to RGB (red), and mean
densities evaluated in the areas of 20 × 20 pixels (400 val-
ues). The areas were measured in control samples (back-
ground) and within ERα and ERβ immunoperoxidase
processed samples (crude values). The measurements
were copied into Microsoft Excel 2002 (Microsoft Corpo-
ration), and background values subtracted from crude
measurements to obtain net optical density (O.D.). Net
values were utilized for statistical calculations. Blots were
quantified as described previously [15].
Statistics
Statistical analysis of data was performed using GraphPad
InStat version 3.01 for Windows software (GraphPad Soft-
ware, San Diego, CA). The net O.D. values of ERα and ERβ
immunoreactivity in immunohistochemistry and western
blots were transformed (Y=Log [Y]) and subjected to Re-
peated Measures Analysis of Variance (ANOVA) followed
by TukeyKramer Multiple Comparisons Test. Probability
values of P < 0.05 were considered significant.
Results
ERβ immunoreactivity in chorionic villi (CV) and placental 
membranes (Figures 1 and 2)
We used dual color immunohistochemistry without he-
matoxylin counterstain to show placental mesenchymal
cells and epithelial structures (left column, Fig. 1). Parallel
sections were investigated for ERβ (mid column) and uti-
lized for controls, where PBS was used instead of the ERβ
antibody (right column). Mesenchymal cells expressing
Thy-1 differentiation protein (brown color) were repre-
sented by pericytes (arrowhead, Fig. 1A), fibroblasts (ar-
rowhead, Fig. 1D) and decidual cells (d, Fig. 1D,1G and
1J). Epithelial structures expressing cytokeratin (blue
color) were represented by ST (s, Fig. 1A) and EVT (t, Fig.
1D and 1J). Strong ERβ immunoreactivity was detected in
villous ST (Fig. 1B) and weaker staining was apparent in
villous sinusoids (arrowheads).
In placental membranes (Fig. 1E), strong ERβ immunore-
activity was confined to amniotic epithelium (e) and EVT
(t). Weak staining was associated with connective tissue
cells and decidual cells (compare with control, panel F).
Decidua in the placental basal plate showed weak ERβ
staining of (d Fig. 1H and 1K, compare with controls), but
basal plate EVT showed strong ERβ immunoreactivity (t,
Fig. 1K).
There was, however a variability of ERβ expression in am-
niotic epithelium (Fig. 2A Note ERβ+ (solid arrow) and
ERβ- nuclei (white arrow). In the basal plate, EVT also ex-
hibited strong (solid arrow) and diminishing ERβ immu-
noreactivity (white arrow, Fig. 2B). Placental vesselsReproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/36
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showed ERβ immunoreactivity restricted to the endotheli-
al cells (ec, panel C). In CV, during association of CT cells
with ST (st), the nuclear ERβ immunoreactivity was appar-
ent (solid arrow, panel D). However, nuclei of differenti-
ated ST were unstained (white arrow). Decidual cells
occasionally (a few cells in one of 7 placentae investigat-
ed) exhibited nuclear ERα (panel E, compare with control,
panel F). Strong ERβ immunoreactivity of EVT (positive
control) is shown in panel G and a lack of immunoreac-
tivity on a parallel section incubated with peptide-ab-
sorbed ERβ antibody (PA/ERβ) is shown in panel H.
Except in panel D, no nuclear counterstain was utilized.
Dual color immunohistochemistry for ERα and ERβ immu-
noreactivity in chorionic villi (Figure 3)
The relationship between ERα and ERβ immunoreactivity
in CV was also investigated by dual color immunohisto-
chemistry (Fig. 3). We observed that dividing CT cells pri-
or to separation (arched arrow) show strong ERα
expression in the parental cell (p; distant from ST) and
weak expression in the daughter (d) merging with very
narrow ST (~2 µm, yellow arrows; Fig. 3A). Note that the
dividing cell exhibits a perpendicular (90 degrees) long
axis to the plane of the ST layer (see discussion for impor-
tance and comment). Additional differentiating daughter
CT cells (d') show brown/blue color contrasting with dark
blue of differentiated syncytium (st). There were also iso-
lated CT cells in the villous stroma (quiescent, q; or G0),
which showed very weak nuclear ERα.
Another strongly ERα+ parental CT cell in the villous stro-
ma is shown in Fig. 3B. Differentiating daughter CT cells
associated with ST showed gradual diminution of ERα
and increase of ERβ (brown and blue arrows) merging
with an ERβ+ (blue) ST. Note that single color staining in
Fig. 2D indicates that the CT cells merging with ST (solid
arrow) exhibit nuclear ERβ. We also occasionally detected
symmetric division of CT resulting in two parental cells
with strong nuclear ERα staining (Fig. 3C Note the parallel
long axis of dividing cells to the plane of ST and relatively
wide ST (~8 µm, orange arrows). Panel D is a control for
dual color immunohistochemistry, where both primary
antibodies were replaced with PBS.
Quantitative evaluation of ERα immunoreactivity in qui-
escent (q), parental (p) and daughter cells (d) during
asymmetric divisions is shown in Fig. 3E. The ERα immu-
noreactivity was lowest in quiescent cells and highest in
parental cells during asymmetric division. However,
daughter cells showed significant diminution of ERα
when compared to parental cells. Statistical analysis indi-
cated overall ANOVA P < 0.0001, and differences between
all columns P < 0.01.
Comparison of ERβ and ERα immunoreactivity in cultured 
trophoblast (Figures 4 and 5)
To determine an association of ERβ and ERα immunore-
activity with differentiation of mononucleated trophob-
last cells into syncytial aggregates, we investigated isolated
cytotrophoblast cells and young and mature syncytial ag-
gregates in tissue cultures. The trophoblast cultures
showed a lack of ERβ immunoreactivity in isolated tro-
phoblast cells (white arrowhead, Fig. 4A). However,
strong staining accompanied young (small) syncytial ag-
gregates (y, panels A and B). Cytotrophoblast cells associ-
ated with small aggregates showed an increase in ERβ
immunoreactivity (arrowhead, panel B). Development of
mature ST aggregates (m, panel C) was associated with
gradual diminution of nuclear staining (solid > white ar-
rows), but persisting cytoplasmic ERβ immunoreactivity.
Panel D shows control staining with PBS and anti-goat
secondary antibody. In contrast, ERα immunoreactivity
was detected in isolated cultured trophoblast cells (arrow-
head, Fig. 4E). The staining persisted in young syncytial
aggregates (y, panels E and F) but diminished in mature
ST (m, panels F and G). Panel D shows control staining
with PBS and anti-mouse secondary antibody.
Quantitative evaluation of ERα and ERβ immunoreactivi-
ty in late tissue cultures is shown in Fig. 5. ERα immuno-
reactivity was highest in isolated CT cells (CT), moderate
in young syncytial aggregates (yST) and virtually undetec-
table (not significantly different from background values)
in mature syncytia (mST). However, ERβ immunoreactiv-
ity was virtually undetectable in isolated CT cells, highest
in young syncytial aggregates, and moderate expression
persisted in mature syncytia. Statistical analysis has shown
overall ANOVA P < 0.0001), and differences between col-
umns with different superscripts P < 0.01.
Expression of ERα and ERβ proteins in vivo and in vitro 
(Figure 6)
We used western blot analysis in order to evaluate overall
expression of ERα and ERβ proteins in vivo and in cul-
tured trophoblast. Expression of ERα and ERβ proteins
was detected in CV, isolated trophoblast cells at time 0
(t:0), and early (EC) and late trophoblast cultures (LC,
Fig. 6A). Both ERs showed higher expression in time 0 and
early cultures when compared to CV and late trophoblast
culture.
We also tested the specificity of primary antibodies in
western blots. When the ERβ antibody was pre-absorbed
with blocking peptide (PA/ERβ), no bands were detected
(Fig. 6B). ERα and ERβ bands in original protein extracts
(lanes 1 and 2) and a lack of ER protein bands in cdk2 IPs
(lanes 3 and 4) is shown in Fig. 6C. Probing for cyclin E
(positive control) showed low molecular weight protein
variants in original protein lysates and IPs.Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/36
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Figure 3
Dual color immunohistochemistry for ERα (brown) and ERβ (dark blue) in CV. [A] Dividing CT cell (arched arrow) shows 
strong ERα staining (brown color) in the parental (p) cell and depletion in the daughter cell (d) merging with ST. A quiescent 
CT cell (q) shows weak nuclear ERα staining. Additional "daughter cells" shoving brown/blue color transition are indicated as 
(d'). Dark blue (ERβ) staining dominates mature ST (st). Yellow arrows indicate very narrow ST. [B] Strong brown nuclear 
ERα immunoreactivity of parental CT cell (p), and gradual diminution of ERα and increase of ERβ in daughter cells (brown and 
blue arrows) merging with ERβ+ (blue) ST. [C] Dividing CT giving rise to two parental cells with high ERα immunostaining. 
Orange arrows indicate relatively wide ST. [D] Control. [E] Quantitative evaluation of ERα immunoreactivity in quiescent, 
parental and daughter cells. Each column represents mean from six net O.D. measurements ± SD. Different column super-
scripts indicate significant difference. Details in text.
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Figure 4
Immunolocalization of ERβ and ERα in the late trophoblast culture (68 h). [A] Isolated CT cells are unstained (arrowhead) but 
strong ERβ nuclear and cytoplasmic immunostaining accompanies young ST aggregates (y). [B] CT cell associated with ST 
shows ERβ immunoreactivity (arrowhead). [C] Mature ST (m) shows a diminution of ERβ nuclear staining (solid > white 
arrows) with persisting cytoplasmic immunoreactivity. [D] Secondary antibody control. [E] Isolated CT cells show strong ERα 
immunostaining (arrowhead) persisting in young ST aggregates [y, E and F] but diminishing in mature ST [m; F and G]. [H] 
Secondary antibody control.
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ERβ hormone binding domain (Figure 7 and 8)
Our observations from CV show nuclear specific reactivity
of E12 antibody with villous ST (full arrows, Fig. 7A vs.
control, 7C). The immunoreactivity of F12 antibody was
similar, but the nuclei of cytotrophoblast cells associated
with ST were also stained (white arrows, Fig. 7B). Both,
E12 and F12 antibodies (Fig. 7D, vs. control, Fig. 7E)
showed nuclear immunoreactivity specifically localized in
amniotic fibroblasts (arrow), epithelium (full arrowhead)
and EVT (white arrowheads).
Western blot analysis with E12 and F12 antibodies (Fig.
8A) showed an abundant expression of a ~64 kDa ERβ
protein variant (64β) in trophoblast cultures. The F12 an-
tibody also revealed a distinct ~68 kDa band (68β), above
the 66 kDa ERα. The expression of this protein was higher
in time 0 and cultured trophoblast (lanes 6–8), as com-
pared to CV (lane 5). This antibody also specifically iden-
tified a 35 kDa (35β), probably ERβ protein fragment (see
ref. [18]), higher in trophoblast cultures (lanes 7 and 8).
However, in protein extracts from CV and trophoblast cul-
tures from this placenta, no prominent band at ~52 kDa
was detected by E12 and F12 antibodies (lines 1–8, Fig.
8A).
For comparison, lane 9 shows a distinct single band re-
vealed by ERβ N-19 polyclonal antibody at ~52 kDa (52β)
in time 0 trophoblast culture (T:0, ERβ pAb). The reactiv-
ity of ERα monoclonal antibody in lane 10 (ERα h-151)
indicates a distinct band at 66 kDa (green arrowhead,
66α), not interfering with the ~64 band identified by E12
antibody and ~64 and 68 kDa bands identified by F12
antibody. Note higher molecular weight narrow bands
(open arrowheads), probably nonspecific reactivities of
ERα and ERβ mouse-anti human monoclonal antibodies.
Figure 8B shows western blot analysis of another placenta.
The expression of ~64 kDa ERβ is most prominent in early
culture (EC), protein extracts from chorionic villi show
distinct ~52 kDa ERβ variant (dotted arrow indicates
adjacent ~53 kDa band), and trophoblast cultures show
~56 kDa band identified with E12 antibody in particular.
Quantitative evaluation of ~64 kDa hormone binding do-
main (Fig. 8C) shows more than three fold increased ex-
pression in trophoblast cultures as compared to the CV
and time 0 protein extracts. Overall ANOVA was P  <
0.0001, post test revealed P < 0.01 differences between
columns with different superscripts. The data indicate that
the expression of ~64 kDa ERβ protein with hormone
binding domain significantly increases in early cultures
Figure 5
Quantitative evaluation of ERα and ERβ immunoreactivity in late trophoblast cultures. CT, cytotrophoblast; yST, young ST; 
mST, mature ST (see Fig. 4 for examples). Each column represents mean from six net O.D. measurements ± SD. Different col-
umn superscripts indicate significant difference. Details in text.
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Figure 6
Representative western blot analysis of ERα and ERβ expression in CV, time 0 separated trophoblast cells (t:0), and early (EC) 
and late trophoblast cultures (LC). [A] All lanes are from the same normal placenta and corresponding cultures, and from the 
same blot. [B] Absorption of ERβ antibody with blocking peptide (PA/ERβ) resulted in a lack of ERβ band detection in CV from 
another placenta and derived trophoblast cultures. [C] Demonstration of ERα and ERβ expression in original protein lysates 
(lanes 1 and 2) and lack of reactivity with cdk2 immunoprecipitates (cdk2 IP; lanes 3 and 4) from time 0 and early trophoblast 
cultures. Bottom is the positive IP control showing cyclin E low molecular weight (cE LMW) protein variants in both original 
lysates and cdk2 IPs.
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(EC vs. CV and T:0) and high expression persists in late
cultures (LC).
Placental localization of ERα and ERβ immunoreactivity 
(Table 2)
ERα and ERβ (~52 kDa) immunoreactivity in various pla-
cental cell types is summarized in Table 2. From trophob-
last cell types, the villous CT expressed ERα only, while ST
and EVT showed ERβ. However, CT cells merging with ST
and young syncytial aggregates showed expression of both
ERs. Other epithelial, mesenchymal or vascular cell types
showed either ERα (pericytes) or ERβ (endothelial cells,
amniotic epithelium, decidua). Rare decidual cells
showed nuclear ERα. Interestingly, nuclear and/or cyto-
plasmic expression of ERs varied depending on the cell
type/stage (see superscripts in Table 2). Both ERs were also
detected in some cells in the extravillous connective tis-
sue. Table 2 also shows that expression of ERβ with
hormone binding domain (~64 kDa) is exclusively nucle-
ar, associated with ST, EVT, and amniotic epithelium and
fibroblasts. Therefore, these placental cell types appear to
Figure 7
Immunoreactivity of the E12 and F12 antibodies recognizing ERβ hormone binding domain in CV and placental membranes. [A] 
The E12 antibody shows nuclear-specific localization of ERβ in villous ST (full arrowheads). [B] The F12 antibody shows 
nuclear-specific localization of ERβ in villous ST and adjacent CT cells merging with ST (white arrowheads). [C] Control for 
panels [A] and [B]. [D] In placental membranes, the F12 (and E12 – data not shown) antibodies showed nuclear-specific local-
ization of ERβ in amniotic epithelium (full arrowhead), fibroblasts (arrow) and EVT (white arrowheads) – compare with control 
in [E]. Bar in [B] for [A–C]; bar in [E] for [D and E].
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Figure 8
Western blot analysis of ERβ hormone binding domain with E12 and F12 monoclonal antibodies. [A] Both antibodies identify 
~64 kDa band, abundant in early (EC) and late cultures (LC). The F12 antibody (lanes 5–8) also identifies a distinct ~68 kDa and 
~35 kDa bands, which show enhanced expression in trophoblast cultures. Note a virtual lack of ~52 kDa ERβ band in lanes 1–
8, identified by polyclonal antibody [ERβ pAb (N-19)] in lane 9. The N-19 antibody (lane 9) does not show any reactivity except 
at ~52 kDa. Lane 10 shows ERα (h-151 antibody) band at 66 kDa (green arrowhead), which does not interfere with ~64 and 
68 kDa reactivity of E12 and F12 antibodies. Open arrowheads indicate narrow bands, possibly non-specific reactivities shared 
among monoclonal antibodies. [B] Protein extracts from another placenta show similar character of expression of ~64 kDa 
ERβ hormone binding domain. Relatively strong ~56 kDa E12 immunoreactivity is also evident in trophoblast cultures. Both 
antibodies identify a distinct ~52 kDa ERβ in protein extracts from chorionic villi (CV), which is barely detectable in trophob-
last cultures. Dotted arrow indicates adjacent ~53 kDa band. [C] Quantitative evaluation of ~64 kDa ERβ protein identified by 
F12 antibody in [A]. Each column represents a mean from six net O.D. measurements ± SD. Different column superscripts 
indicate P < 0.01.
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be responsive to estrogens via the nuclear ERβ hormone
binding domain.
Expression of the cell cycle-related proteins in the placen-
ta and derived cultures (Figure 9)
To understand better the role of other proteins involved in
the regulation of trophoblast proliferation and differenti-
ation in vivo and in vitro, we also compared expression of
some cell cycle-related proteins in vivo and in vitro. In
normal placentae, the expression of cyclin E (cE), which is
involved in the stimulation of cell cycle progression [37],
was low, as was that of p27 (cE antagonist) promoting ter-
minal differentiation of cells [38] (lane 5, Fig. 9A). This is
in agreement with occasional trophoblast proliferation in
normal term placentae [25], apparently not prevented by
high p27 expression. In early cultures, expression of both
proteins increased significantly (lane 1, Fig. 9A; see also
panel B for quantitative evaluation). During culture, ini-
tially high expression of cE significantly decreased at 45
and 70 hours, and remained low at 94 hours. However,
moderate expression of p27 in early cultures significantly
increased at 45 hours and remained extremely high till the
end of the culture. These trends were observed in all
cultures from normal placentae investigated. Such obser-
vations indicate that the p27 antiproliferative effect may
play an important role in the prevention of cultured tro-
phoblast proliferation and, therefore, promote an overall
tendency of cultured trophoblast cells toward terminal
differentiation (see also Discussion).
Discussion
To our knowledge, this is the first study showing placental
ERβ protein expression by western blot analysis and ERβ
immunoreactivity in placental cell types. We also show a
comparison of placental ERα and ERβ protein expression
and cellular localization. Our observations indicate that
various cellular components of human placenta express
either ERα or ERβ. Furthermore, we show in vivo and in
vitro that ERα+/ERβ- CT cells differentiate into ERα+/
ERβ+ young and ERα-/ERβ+ mature ST aggregates.
In situ hybridization and immunolocalization of ERα and
ERβ in a variety of reproductive tract tissues in males and
females have shown that in most instances either ERα or
ERβ is expressed in a particular cell type, although some
cell types, e.g., Leydig cells, ovarian surface epithelium,
and epithelial and stromal cells of the uterus and breast,
may show expression of both ERs [39–41]. However,
since only a proportion of cells were detected to express
ERα or ERβ in a single color immunohistochemistry [42],
such an approach cannot demonstrate coexpression of the
ERs in a particular cell, nor indicate eventual transition
from one ER subtype to another during differentiation.
However, recent double color immunohistochemistry ex-
periments indicate that the cells in the mouse proximal ef-
ferent ductule epithelium can be separated into three
types with distinct expression of ERs: (1) ERα+/ERβ-, (2)
ERα+/ERβ+ and (3) ERα-/ERβ+ [43]. The authors did not
provide any functional explanation of these observations.
Nevertheless, our study also shows that these three types
of ER expression can be detected in villous trophoblast.
Moreover, our data indicate that there is a switch in ER ex-
pression from type (1) ERα+/ERβ- to type (2) ERα+/ERβ+
and finally to type (3) ERα-/ERβ+ during trophoblast
differentiation in vivo, and this observation was con-
firmed by the study of trophoblast differentiation in vitro.
As mentioned in the Introduction, recent studies of the
functional significance of ERβ in βERKO mice show that
ERα is sufficient for basic differentiation of estrogen-sen-
sitive tissue. However, a lack of ERβ results in a defect in
terminally differentiated tissue morphology [23] and in-
dicates that ERβ expression is required for terminal differ-
entiation of estrogen-dependent cells. Our study concurs
with such observations, since we show that ERβ expres-
sion is associated with terminal differentiation of
trophoblast. Moreover, we show a switch from nuclear to
cytoplasmic ERβ expression in terminally differentiated
ST and EVT. In addition, the decidual cells, which are
known to exhibit degenerative changes at term [44], show
Table 2: Expression of ERα, and ~52 and 64 kDa ERβ in human term placentae
Placental cell type ERα ERβ (N-19,~52 kDa) ERβ (E12, ~64 kDa)
Villous cytotrophoblast +a -b -
Syncytiotrophoblast - +c +a
Vascular pericytes +d --
Endothelial cells - +a -
Extravillous trophoblast - +d +a
Extravillous fibroblasts +d +d +a
Amniotic epithelium - +a +a
Decidua (+)e +c -
aNuclear. bCoexpression with ERα during early differentiation of CT cells. c Cytoplasmic. dNuclear/cytoplasmic. e Rare occurrence.Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/36
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Figure 9
Representative comparison of cyclin E and p27 protein expression in vivo and in vitro. [A] Normal placenta shows a weak 
expression of cyclin E low molecular weight variants (cE LMW, lane 5). Early trophoblast culture shows high cE LMW expres-
sion (lane 1) followed by gradual diminution (lanes 2–4). p27 expression is also weak in vivo, but gradually increases during tro-
phoblast cultivation. [B] Quantitative evaluation of cE LMW and p27 blots. Each column represents mean from six net O.D. 
measurements ± SD. Different column superscripts (with identical color) indicate P < 0.001.
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marked diminution of cytoplasmic ERβ. This suggests that
terminal aging and degeneration of estrogen responsive
cells are accompanied by a progressive loss of ERβ
expression.
Our ERα and ERβ single and dual color immunohisto-
chemistry experiments show that daughter CT cells de-
rived from ERα+ parental cells coexpress both ERs during
early stages of differentiation, and lose ERα during their
terminal differentiation into the ST. The differentiation of
CT was associated with very narrow (~2 µm) ST, which
may need complementation by additional CT cells to
function. However, the parental and daughter cells
showed in vivo differences in nuclear ER immunoreactiv-
ity prior to their complete separation. While the parental
cell showed high nuclear ERα, the daughter cell associated
with ST showed marked diminution of ERα
immunoreactivity and an increase of differentiation-asso-
ciated ERβ protein.
These observations parallel recent studies that postmitotic
cells may exhibit asymmetric distribution of the differen-
tiation-associated proteins prior to their separation.
Asymmetric division may involve extrinsic (influence of
adjacent cells) or intrinsic factors. Among the intrinsic
factors underlying asymmetric division, the interactions
of the Numb differentiation-associated protein with
Notch proliferation-associated signaling is the model
most widely studied, ranging from bacteria, yeast, and
Drosophila to mammals [30]. When the neuronal pro-
genitor cells undergo asymmetric division (20% in neuro-
nal tissue cell culture) they produce neuronal daughter
cells to which Numb protein segregates preferentially, and
such daughter cells show an enhanced differentiation of
neuronal processes [45]. Interestingly, Numb is firstly as-
sociated with one pole of the plasma membrane of a di-
viding cell, and subsequently with one of the two
resulting nuclei [29,45]. Our study indicates that preserva-
tion of nuclear ERα in one of two postmitotic cells is asso-
ciated with the ability of CT to replicate and diminution
of ERα and appearance of nuclear ERβ dictates a genera-
tion of a daughter cell that is committed to differentiate
(Fig. 10).
The model presented in Fig. 10 can be used to explain, at
least in part, the role of ERs in proliferation and differen-
tiation of other estrogen-dependent cell types. However, it
has to be considered that ERs are certainly not the only
proteins which are involved in decisions of estrogen-de-
pendent cells to proliferate or differentiate. At least cell cy-
cle related proteins, either suppressors or facilitators, and
growth factors and cytokines produced by stromal cells
[1,46–49] should be considered in addition to the promi-
totic effect of E2 mediated via ERα. Figure 10 may not be
applicable for transformed cells with abnormal ER vari-
ants, or cells exhibiting only one type of ER. For example,
expression of ERβ only may indicate that differentiation
but not proliferation is estrogen-dependent.
Former studies also indicated that the decision between
symmetric and asymmetric division in vivo depends on
the mitotic spindle orientation. During fly neurogenesis,
the neuroblasts delaminate from a monolayer of ectoder-
mal cells. The ectodermal cells at the surface of the Dro-
sophila embryo divide with the axes of their mitotic
spindle parallel to the plane of the ectodermal monolayer.
In contrast, a neuroblast divides along the apical-basal ax-
is, so that the axes of its mitotic spindles are perpendicular
to the plane of the ectodermal layer. Thus, the mitotic
spindle of the neuroblast has to reorientate by 90 degrees
Figure 10
Simplified schematic view of ERα and ERβ differential expres-
sion during asymmetric division and differentiation of villous 
trophoblast cells in vivo (postmitotic cell surface and cyto-
plasmic ERα expression – see ref. [15], is not included). pCT, 
parental CT; dC1T, differentiating CT; mST, mature ST; p, 
postmitotic parental cells; d, postmitotic daughter cells. 
Details in text.
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from the plane of the ectodermal layer [50].The orienta-
tion of the mitotic spindle correlates with the asymmetric
distribution of Numb [29].
Figure 3A shows that similar perpendicular orientation,
i.e., 90 degrees from the plane of ST layer (toward the vil-
lous core), applies for asymmetrically dividing villous CT.
Hence, in CV, one pole of dividing CT cells is associated
with mature ST and the other with the mesenchymal vil-
lous core (stroma). It is possible to speculate that the
poles of dividing CT cells are influenced differently – the
juxta-syncytial pole toward differentiation and juxta-mes-
enchymal toward proliferation. Therefore, the extrinsic
factors (type of neighboring cells) may dictate asymmetric
segregation of intrinsic factors determining the fate of di-
viding cells. In other words, asymmetric division in vivo
may be a result of the influence of both extrinsic and in-
trinsic factors. If so, the extrinsic factors should be viewed
as inducers and intrinsic factors as effectors of asymmetric
division. Based on available data [29,30,45,50–52] and
our observations, a possible sequence of events involved
in asymmetric division of villous CT cells is given in Fig-
ure 11A. Note an involvement of stromal (stimulation of
CT division) and ST signaling (stimulation of cell differ-
entiation). Figure 11B indicates that symmetric division of
ST may result from the presence of stromal and absence of
ST signaling.
However, perpendicular orientation of dividing trophob-
last cells in vivo cannot be achieved in vitro, because the
complex villous structure, and the villous core in particu-
lar, is absent. Although ERα > ERβ transition was also ob-
served during trophoblast differentiation in culture, the
cultured trophoblast cells are expected to undergo sym-
metric division toward the differentiated phenotype
rather than asymmetric division. Indeed, early cultures
show proliferating CT cells, which are gradually trans-
formed into the differentiating CT cells and syncytial ag-
gregates during the culture [15], possibly due to the
prevalence of differentiation signals in the absence of stro-
mal signaling (Figure 11C). This view is supported by
gradual diminution of promitotic cyclin E and an increase
of antimitotic p27 proteins during trophoblast culture
(Fig. 9). Finally, regarding the placenta, it is important to
consider the stage of pregnancy. For early pregnancy, the
scheme in Figure 10 can possibly be extended to other cell
types (decidua, EVT), in contrast to the term placenta
where only villous CT cells are dividing [25–27].
We recently showed that exogenous E2 markedly stimu-
lates development of large syncytial aggregates in tro-
phoblast cultures [15]. We also observed that this effect
can be abolished with pure anti-estrogen ICI 182,780
(unpublished data). These data indicate that trophoblast
differentiation is estrogen-dependent. Since trophoblast
differentiation is associated with transition from ERα to
ERβ expression, with temporary co-expression of both,
one may assume that both ERs are involved in estrogen
stimulated trophoblast differentiation. Since production
of placental hormones is characteristic of mature
syncytium [5,9,11,53,54], which shows in vivo cytoplas-
mic ERβ expression only, one may also assume that estro-
gens stimulate production of placental hormones by ST.
Studies on localization and expression of ERβ hormone
binding domain recognized by E12 and F12 monoclonal
antibodies in human placenta are of particular interest.
Immunohistochemical studies with these antibodies by
Choi et al. [18] revealed nuclear-specific localization of
the ERβ protein in granulosa cells of the rat ovary and in
Figure 11
Structure-related arrangement of asymmetric division (prolif-
eration and differentiation) of villous CT cells. [A], symmet-
ric division resulting in proliferation [B], and symmetric 
division resulting in differentiation [C]. m, metaphase; t, telo-
phase; d, differentiating cell; EC, early trophoblast culture; 
LC, late culture. Relevant references and details are given in 
text.
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epithelial and some stromal cells of mouse and rat epidi-
dymis. Specificity of the E12 and F12 monoclonal anti-
bodies was verified by western blot analysis using
baculovirus expressed form of human ERβ (53 kDa) [18].
These antibodies were also reported to identify an addi-
tional ~62–64 kDa band in protein extracts from granulo-
sa cells of several mammalian species, in addition to the
~52 kDa band [18].
Our observations on human placenta show that E12 and
F12 antibodies exhibit nuclear-specific reactivity with
placental ST. Therefore, cytoplasmic reactivity in mature
ST detected by N-19 polyclonal antibody, which recogniz-
es a single ~52 kDa band, might not be related to the ERβ
variant with a hormone binding domain. Indeed, in hu-
man trophoblast cultures, the E12 and F12 antibodies are
shown to exhibit virtually no reactivity with the ~52 kDa
variant and the N-19 polyclonal antibody shows no reac-
tivity at ~64 kDa. Therefore, one may speculate that the
placental ~52 kDa ERβ variant is not necessarily a hor-
mone binding protein. One may also assume that the pla-
cental ERβ hormone binding variant recognized by E12
and F12 antibodies does not contain or expose epitopes
which are recognized by the N-19 ERβ polyclonal anti-
body which shows reactivity with trophoblast cultures.
The E12 and F12 antibodies have been shown to react
with baculovirus expressed ~53 kDa form of human ERβ
protein [18]. Yet, it is possible that mammalian cells nat-
urally expressing ERβ produce two protein variants, with
and without ERβ hormone binding domain, resulting
from (post-) translational modifications of the ERβ
protein.
Interestingly, villous cytotrophoblast cells merging with
syncytium showed nuclear-specific F12, but not E12 im-
munoreactivity. Hence, the epitope associated with the
~64 kDa ERβ hormone binding variant recognized by E12
and F12 can be excluded, but the ~68 kDa variant recog-
nized by F12 might be considered to be involved in early
trophoblast differentiation. Since the F12 antibody also
failed to recognize a distinct ~52 kDa band in human
granulosa cell protein extracts [18], and the E12 antibody
did not show any reactivity at ~68 kDa, one may speculate
that the ~68 kDa band might be another ERβ protein var-
iant. Indeed, it has been indicated that it is unlikely that
the E12 and F12 antibodies recognize exactly the same
state of the epitope since the F12 antibody was much
more efficient in immunoprecipitation of the native ERβ
protein generated in vitro [18]. We also show that E12 an-
tibody identifies the ~56 kDa band in trophoblast cultures
barely visible in extracts analyzed by F12 antibody (Fig.
8B).
Nevertheless, as compared to CV and time 0 protein ex-
tracts, trophoblast differentiation in early and late tissue
cultures was associated with a more than three fold in-
crease of the ~64 kDa ERβ hormone binding variant (Fig.
8C), while the ~52 kDa protein identified by N-19 poly-
clonal antibody showed a tendency to decline in late cul-
tures (Fig. 6A). Therefore, the ERβ hormone binding
protein appears to play a dominant role in the hormone-
stimulated terminal differentiation of trophoblast, while
the ~52 kDa ERβ protein might be somehow related to the
non-hormonal regulation of early stages of trophoblast
differentiation (see proposed role of ERβ in asymmetric
division of estrogen-dependent cells discussed above).
The importance of ERβ hormone binding variants in stim-
ulation of terminal trophoblast differentiation is
supported by our observation on the stimulatory effect of
E2 for the formation of large syncytial aggregates [15].
From the above it appears that in human placenta, there
are at least two ERβ proteins: (1) the cytoplasmic and nu-
clear ~52 kDa ERβ with N-terminal related epitopes recog-
nized by N-19 polyclonal antibody and lacking a
hormone binding domain recognized by the E12 and F12
antibodies, and (2) the nuclear-specific ~64 kDa ERβ with
a hormone binding domain recognized by E12 and F12
antibodies and lacking epitopes recognized by N-19 poly-
clonal antibody. The existence of these two distinct ERβ
proteins is particularly supported by their different expres-
sion in trophoblast cultures (compare Fig. 6A and 8A and
8B). A possibility exists that there is an additional ~68
kDa ERβ protein, which is recognized exclusively by the
F12 antibody (Fig. 8A and 8B) and expressed in the nuclei
of early differentiating trophoblast cells merging with ST
(Fig. 7B).
Conclusion
In conclusion, our observations concur with recent views
on the importance of ERα in the proliferation and ERβ in
the maturation of estrogen-dependent cells. Asymmetric
segregation of ERα in dividing villous CT cells, accompa-
nied by appearance of ERβ in differentiating daughter
cells, suggests a unique role of ERs in asymmetric division
of estrogen-dependent cells. Significantly enhanced ex-
pression of the ~64 kDa ERβ hormone binding variant in
differentiating trophoblast cells and stimulation of tro-
phoblast differentiation by estrogens indicates a unique
role of the ERβ hormone binding domain in the
regulation of placental function. Since ST is a major
source of placental hormones, which ensure optimal con-
ditions for the fetus and mother, ERβ expression by ST
may be involved in stimulation of placental hormonal
production by estrogens.
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